Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
$148M |
| 2 |
GE HealthCare
GEHC
|
$118M |
| 3 |
Atlassian
TEAM
|
$101M |
| 4 |
Monster Beverage
MNST
|
$81.1M |
| 5 |
PACCAR
PCAR
|
$48.1M |
Top Sells
| 1 |
Apple
AAPL
|
$360M |
| 2 |
Microsoft
MSFT
|
$199M |
| 3 |
NVIDIA
NVDA
|
$99.2M |
| 4 |
Amazon
AMZN
|
$85.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$83.8M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.45% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTX
2601
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $314K | ﹤0.01% | +102,100 | New | +$314K |
|
|
LBC
2602
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $314K | ﹤0.01% | 33,100 -3,900 | -11% | -$37K |
|
|
SNPO
2603
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $307K | ﹤0.01% | 32,800 -3,100 | -9% | -$29K |
|
|
NYAX
2604
Nayax
NYAX
$1.84B
| $303K | ﹤0.01% | 17,890 -1,579 | -8% | -$26.8K |
|
2605
Cullinan Oncology
CGEM
$445M
| $303K | ﹤0.01% | 29,600 -3,400 | -10% | -$34.8K |
|
2606
BRC Inc
BRCC
$176M
| $303K | ﹤0.01% | 58,900 -2,500 | -4% | -$12.9K |
|
|
IGMS
2607
DELISTED
IGM Biosciences
IGMS
| $302K | ﹤0.01% | 22,000 -2,500 | -10% | -$34.4K |
|
|
WE
2608
DELISTED
WeWork Inc.
WE
| $297K | ﹤0.01% | 382,000 -46,200 | -11% | -$35.9K |
|
2609
Atlanticus Holdings
ATLC
$1.01B
| $296K | ﹤0.01% | 10,900 -1,600 | -13% | -$43.4K |
|
2610
Amneal Pharmaceuticals
AMRX
$3B
| $295K | ﹤0.01% | 212,500 -25,100 | -11% | -$34.9K |
|
2611
Latham Group
SWIM
$936M
| $289K | ﹤0.01% | 101,100 -12,300 | -11% | -$35.2K |
|
2612
Phathom Pharmaceuticals
PHAT
$864M
| $288K | ﹤0.01% | 40,400 -1,100 | -3% | -$7.85K |
|
|
MMAT
2613
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $287K | ﹤0.01% | 703,100 -81,000 | -10% | -$33K |
|
2614
Nektar Therapeutics
NKTR
$568M
| $285K | ﹤0.01% | 405,700 -46,800 | -10% | -$32.9K |
|
2615
Stoke Therapeutics
STOK
$1.08B
| $284K | ﹤0.01% | 34,100 -3,100 | -8% | -$25.8K |
|
|
BHIL
2616
DELISTED
Benson Hill, Inc.
BHIL
| $282K | ﹤0.01% | 245,100 -28,000 | -10% | -$32.2K |
|
|
AEVA
2617
Aeva Technologies
AEVA
$834M
| $280K | ﹤0.01% | 235,600 -18,700 | -7% | -$22.3K |
|
2618
Holley
HLLY
$490M
| $280K | ﹤0.01% | 102,100 -11,800 | -10% | -$32.3K |
|
2619
Esperion Therapeutics
ESPR
$448M
| $274K | ﹤0.01% | 172,500 +35,900 | +26% | +$57.1K |
|
|
VLD
2620
DELISTED
Velo3D, Inc.
VLD
| $274K | ﹤0.01% | 120,700 -9,100 | -7% | -$20.7K |
|
2621
Advantage Solutions
ADV
$593M
| $273K | ﹤0.01% | 172,500 -15,100 | -8% | -$23.9K |
|
2622
Organogenesis Holdings
ORGO
$653M
| $271K | ﹤0.01% | 127,100 -9,300 | -7% | -$19.8K |
|
|
CRGE
2623
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $270K | ﹤0.01% | 245,295 -28,500 | -10% | -$31.4K |
|
|
HA
2624
DELISTED
Hawaiian Holdings, Inc.
HA
| $254K | ﹤0.01% | 27,709 -2,600 | -9% | -$23.8K |
|
|
NGM
2625
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $252K | ﹤0.01% | 61,700 -4,100 | -6% | -$16.7K |
|